Task: Answer the multiple choice question.
Query: Which drug exhibits a 8.032\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any other words.
Options:
a Cc1ccc(N2C(=O)N(CC(=O)NC(N)=O)C(=O)C2C)cc1
b Cc1ccc(-c2nnc(N(C)C(=O)C3CCCO3)s2)cn1
c COc1ccccc1N=Nc1c(O)[nH]c2ccc(Br)cc12
d Clc1ccc(N2CCN(/N=C/c3cccnc3)CC2)cc1
Answer: d. Clc1ccc(N2CCN(/N=C/c3cccnc3)CC2)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Clc1ccc(N2CCN(/N=C/c3cccnc3)CC2)cc1
Clc1ccc(N2CCN(/N=C/c3cccnc3)CC2)cc1
(E)-N-[4-(4-chlorophenyl)piperazin-1-yl]-1-pyridin-3-ylmethanimine